The North America peptide hormones market is witnessing significant growth due to the rising prevalence of endocrine disorders, metabolic diseases, growth hormone deficiencies, and reproductive health conditions. Increasing adoption of peptide-based therapeutics, supported by advancements in biotechnology and peptide synthesis technologies, is driving market expansion across the region. Strong...